A phase 1, open-label, dose escalation study of ADG116 in patients with advanced/metastatic solid tumors [ADG116-1003].

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Baker, Emma (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date24/09/2031/12/23

Keywords

  • Medical oncology
  • Metastatic solid tumors
  • Clinical trial